Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Using aspirin for colorectal cancer prevention

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 24.10.19
Views: 382

Prof Paola Patrignani - University of Chieti, Chieti and Pescara, Italy

Prof Paola Patrignani speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the use of aspirin for colorectal cancer prevention.

She outlines her studies which look at using low dose aspirin to reduce the chance of mutagenesis and metastases.

Prof Patrignani briefly explains some preexisting guidelines, but also the research needed to further develop and clarify these dosages.

Read more about the conference here.

Related videos

follow us

Biosimilar Medicines Core Principles and Communication

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation